Theriva Biologics, Inc. (TOVX)

Theriva Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	13.06	11.61	23.18	41.79	67.33
Cash & Short-Term Investments	13.06	11.61	23.18	41.79	67.33
Cash Growth	12.46%	-49.91%	-44.53%	-37.93%	981.18%
Other Receivables	3.35	3.23	1.61	-	-
Total Trade Receivables	3.35	3.23	1.61	-	-
Other Current Assets	1.06	1.44	2.61	3.73	1.53
Total Current Assets	17.47	16.28	27.4	45.52	68.86
Net Property, Plant & Equipment	1.03	1.54	2.16	1.54	1.48
Other Intangible Assets	19.62	17.36	19.56	19.15	-
Goodwill	-	-	5.7	5.53	-
Other Long-Term Assets	0.13	0.17	0.18	0.12	0.02
Total Assets	38.24	35.35	55.22	71.86	70.37
Accounts Payable	1.01	0.86	0.77	0.92	0.98
Accrued Expenses	6.72	4.51	4.51	2.9	2.45
Short-Term Debt	0.06	0.06	0.06	0.06	-
Current Portion of Leases	0.55	0.54	0.49	0.22	0.12
Other Current Liabilities	1.68	1.61	0.91	2.97	-
Total Current Liabilities	10.01	7.59	6.74	7.06	3.55
Long-Term Debt	1.67	0.09	0.16	0.22	-
Long-Term Leases	0.35	0.87	1.44	1.19	1.4
Other Long-Term Liabilities	10.82	7.74	7.18	8.83	-
Total Long-Term Liabilities	12.84	8.7	8.78	10.24	1.4
Total Liabilities	22.86	16.29	15.52	17.3	4.96
Common Stock	0.03	0	0	0.02	0.01
Treasury Stock	-0.29	-0.29	-0.29	-0.29	-
Additional Paid-in Capital	373.59	355.5	346.54	343.75	336.68
Accumulated Other Comprehensive Income	0.76	-1.18	0.03	-0.68	-
Retained Earnings	-358.71	-334.97	-309.32	-290.97	-271.28
Total Common Shareholders' Equity	15.38	19.07	36.96	51.83	65.41
Minority Interest	-	-	2.73	2.73	-
Shareholders' Equity	15.38	19.07	39.7	54.56	65.41
Total Liabilities & Equity	38.24	35.35	55.22	71.86	70.37
Total Debt	2.63	1.57	2.15	1.68	1.53
Net Cash (Debt)	10.43	10.04	21.02	40.11	65.8
Net Cash Growth	3.81%	-52.22%	-47.58%	-39.05%	1043.52%
Net Cash Per Share	0.86	7.45	32.63	65.41	134.97
Book Value	15.38	19.07	36.96	51.83	65.41
Book Value Per Share	1.27	14.14	57.37	84.54	134.17
Tangible Book Value	-4.24	1.71	11.71	27.16	65.41
Tangible Book Value Per Share	-0.35	1.27	18.17	44.29	134.17

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q